NASDAQ:RTIX RTI Surgical (RTIX) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free RTIX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.12▼$3.3050-Day Range$3.14▼$3.1452-Week Range$1.46▼$5.40Volume686,036 shsAverage Volume622,541 shsMarket Capitalization$234.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get RTI Surgical alerts: Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About RTI Surgical Stock (NASDAQ:RTIX)Surgalign Holdings, Inc. is a global medical technology company, which engages in designing, developing and manufacturing biologic metal and synthetic implants worldwide. It focuses on delivering spine solutions that drive clinical and economic outcomes. The company markets its products throughout the United States and other countries worldwide through an expanding network of independent distributors. The company was founded in February 1998 and is headquartered in Deerfield, IL.Read More Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. RTIX Stock News HeadlinesFebruary 2, 2024 | msn.comAlachua-based RTI Surgical completes purchase of Cook BiotechNovember 27, 2023 | benzinga.comRTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast ReconstructionMay 2, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.May 18, 2023 | thestreet.com3 Health Care Stocks Under $10 to WatchMay 4, 2023 | finance.yahoo.comRTI Introduces New Connext Observability Framework to Maximize the Performance and Availability of Intelligent SystemsMay 7, 2022 | msn.comRTI Surgical is growing its footprint in Progress Park as the biotech industry continues to develop in AlachuaMarch 29, 2022 | investing.comRTIX_old Historical DataSee More Headlines Receive RTIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RTI Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/30/2020Today5/02/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical Appliances & Supplies Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:RTIX CUSIP74975N10 CIK1100441 Webwww.rtix.com Phone(877) 343-6832FaxN/AEmployees891Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-211,640,000.00 Net Margins-70.56% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$308.38 million Price / Sales0.76 Cash Flow$0.30 per share Price / Cash Flow10.31 Book Value$2.89 per share Price / Book1.09Miscellaneous Outstanding Shares74,601,000Free FloatN/AMarket Cap$234.25 million OptionableOptionable Beta2.14 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesTerry M. RichPresident, Chief Executive Officer & DirectorJonathon Mark SingerChief Financial & Operating OfficerLennox K. ArchibaldMedical DirectorG. Bryan CornwallEVP-Research & Clinical AffairsDouglas S. BireleyExecutive VP-Marketing, Research & DevelopmentKey CompetitorsSanara MedTechNASDAQ:SMTIInogenNASDAQ:INGNEnvoy MedicalNASDAQ:COCHCollPlant BiotechnologiesNASDAQ:CLGNJin Medical InternationalNASDAQ:ZJYLView All Competitors RTIX Stock Analysis - Frequently Asked Questions How were RTI Surgical's earnings last quarter? RTI Surgical Holdings, Inc. (NASDAQ:RTIX) announced its earnings results on Tuesday, June, 30th. The medical equipment provider reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.04. The medical equipment provider had revenue of $73.73 million for the quarter. Read the conference call transcript. What other stocks do shareholders of RTI Surgical own? Based on aggregate information from My MarketBeat watchlists, some companies that other RTI Surgical investors own include LightPath Technologies (LPTH), EXFO (EXFO), TherapeuticsMD (TXMD), Merit Medical Systems (MMSI), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD), Pfizer (PFE), Sorrento Therapeutics (SRNE) and Biocept (BIOC). This page (NASDAQ:RTIX) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTI Surgical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.